Overactivation of MYC in adaptive immune cell subsets mainly reduces the killing effect on the tumor by inhibiting effector T cells, in which MYC regulates the expression of CD47 and PD-L1 in various types of tumor cells [8, 30]. The gene discussed is CD47; the disease is neoplasm.